SCHEMBL7262256

SCHEMBL7262256

O=C(O)c1c[nH]c(=O)c(Cc2ccccc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47
DAO P14920 3/20 0.45
KDM4A O75164 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NR4A2 P43354 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PNP P00491 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HCRTR1 O43613 1/20 0.40
ADORA2A P29274 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472533 0.86 AKR1B1 (0.40) PDE3BPDE3ADAONR4A2NPC1
SCHEMBL14604111 0.82 GAA (0.45) PDE3BPDE3ADAOSMN1; SMN2RAB9A
SCHEMBL6471052 0.79 RNASEH1 (0.47) KDM4AKDM5BPNP
SCHEMBL16881268 0.78 NAPRT (0.34) PDE3BPDE3ADAOKDM4AKDM4C
SCHEMBL16486420 0.76 TSHR (0.43) DAOKDM4CRAB9AKDM4EKMT2A
SCHEMBL16880471 0.76 NAPRT (0.39) DAOKDM4CKDM4E
SCHEMBL4649823 0.75 KDM4E (0.45) DAOKDM4AKDM4CSMN1; SMN2NPC1
SCHEMBL7432519 0.74 DAO (0.42) PDE3BPDE3ADAOSMN1; SMN2RAB9A
SCHEMBL4969020 0.73 TSHR (0.42) LMNASMN1; SMN2KDM4EMAPTMEN1
SCHEMBL6209517 0.73 NOTUM (0.53) DAONPC1RAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1360489-A1 LOW AFFINITY SCREENING METHOD Graffinity Pharmaceuticals Aktiengesellschaft (DE) 2003-11-12 EP disclosed
WO-2002063299-A1 LOW AFFINITY SCREENING METHOD GRAFFINITY PHARMACEUTICALS AG (DE) 2002-08-15 WO disclosed